MERTK and autoimmune disease: With the current interest in MERTK as a therapeutic target in autoimmune diseases, and indeed its use as a marker of tolDCs in human trials [5,9], it is important to understand the mechanisms by which MERTK signalling could promote a tolerogenic phenotype in DCs.